EXACT Sciences Corporation (EXAS) Names Michael S. Wygza To Its Board Of Directors

Exact Sciences Corp. (NASDAQ: EXAS) today announced the appointment of Michael S. Wygza to its board of directors. Wygza most recently served as President, Chief Executive Officer and a member of the board of directors of Radius Health, Inc.

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.